PAR
Click for more information
0.00% 28.0¢ paradigm biopharmaceuticals limited..

Ann: 2023 Annual Report and Appendix 4E, page-9

  1. Zenox
    1,216 Posts.
    lightbulb Created with Sketch. 1375
    clock Created with Sketch.
    25/08/23
    17:28
    Post #: 69555517
    Release was slightly after NSB's AR, so I guess you can say it was due to PR being stretched a bit thin.
    PAR Price at posting: 71.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $97.94M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 1200 1
View Market Depth
Last trade - 09.50am 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.